Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation.

BORIS DOI
Publisher DOI
PubMed ID
36655227
Description
The divergent views on lung cancer treatments in fibrosing lung patients reflect differences due to variable side-effect incidences in different countries and among ethnicities. International efforts are needed to better define treatment approaches.
Date of Publication
2022-10
Publication Type
Article
Subject(s)
Language(s)
en
Contributor(s)
Poletti, Venerino
Wells, Athol U
Cadranel, Jacques
Additional Credits
Series
ERJ Open Research
Publisher
European Respiratory Society
ISSN
2312-0541
Access(Rights)
open.access
Show full item